SARS‐CoV‐2 pandemic and the need for transplant‐oriented trials.

To the Editors, After the first reported case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China, in December 2019, the contagion has spread rapidly and has become a global pandemic [1]. 2 The research of the clinical trials has been done using the following keywords: COVID, COVID-19, SARS-CoV-2 or novel coronavirus, together with the name of each drug (https://clinicaltrials.gov. While post hoc analyses may allow to define characteristic responses in transplant patients, ad hoc trials are urgently needed in transplant patients. [Extracted from the article]